Compare Cassava Sciences Inc (FLNA) vs Carparts.Com Inc (PRTS) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

PRTS trades at $5.66, down 3.99% today, with a bearish technical signal but recent earnings beats. The company reported a net loss of $50.44M in 2025, though revenue was $547.53M. A recent reverse stock split and new credit facility aim to stabilize operations. Analyst consensus is 60% buy with no sell ratings, indicating Wall Street optimism despite financial challenges.

Outlook hinges on cost control and revenue stabilization; risks include persistent losses and competitive pressures. The stock presents a speculative opportunity if operational improvements continue, but investors face significant downside if turnaround efforts falter amid weak cash flow and negative profitability metrics.